Pfizer acquired NextWave Pharmaceuticals in a potential $680 million deal for a liquid extended-release methylphenidate (Riatilin), marketed as Quillivant XR. Under the terms of the agreement, Pfizer is set to pay...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)
+65 6592-6978